Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06527326
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-25
Brief Title:
the Study of the Association Between the Gut Microbiota and Central Serous Chorioretinopathy
Sponsor:
None
Organization:
None
Study Overview
Official Title:
the Study of the Association Between the Gut Microbiota and Central Serous Chorioretinopathy
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To investigate the potential association between gut microbiota and central serous chorioretinopathy CSC we have observed in our clinical practice that CSC patients often experience chronic gastrointestinal issues This observation has led us to hypothesize that CSC may be associated with gut dysbiosis The Bifidobacterium genus is widely recognized as a beneficial gut bacterium and numerous well-established Bifidobacterium supplements are available on the market To explore this possible connection we will collect fecal samples from both CSC patients and healthy individuals Using whole-metagenome shotgun sequencing we will compare the gut microbiota compositions of the two groups to determine if significant differences exist Additionally we will randomly assign patients to two groups one group will receive Bifidobacterium supplements for at least one month while the other group will receive a placebo We will then assess whether the group receiving the supplements experiences faster recovery and lower relapse rates compared to the placebo group
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None